Celldex Therapeutics, Inc.

CLDX - Company ID 0000744218

Market cap$3.06 B

Rank#1809

Filings1,268

Celldex Therapeutics, Inc. has filed 1,268 public company documents between 1995 and 2026. The most frequent type is insider trade (458 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchCLDX overview$3.06 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1809See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with IDXXPeer viewPut CLDX beside IDXX across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow CLDX via RSS

Similar companies to research next

IDXXIDEXX Laboratories, Inc.LLNTHLantheus Holdings, Inc.

NTLAIntellia Therapeutics, Inc.

NEOGNeogen Corporation NNNNNAnbio Biotechnology

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
424B2	Prospectus supplement	16y ago2009-10-30	-	View filing
424B2	Prospectus supplement	22y ago2004-02-17	-	View filing
424B2	Prospectus supplement	24y ago2001-10-17	-	View filing
424B2	Prospectus supplement	25y ago2001-02-06	-	View filing
424B2	Prospectus supplement	25y ago2000-08-22	-	View filing

Celldex Therapeutics, Inc.

Similar companies to research next

Year